Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07675109
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Noctrix Health Headquarters Pleasanton, California, United States
Not Yet Recruiting
Study on the Mechanism of Gut Microbiota Mediating Restless Legs Syndrome Through Iron Metabolism
NCT07307482
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
Not specified
NCT07561476
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Pamukkale University Faculty of Physical Therapy and Rehabilitation Denizli, Turkey (Türkiye)
Completed
A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
NCT03053427
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Site JP00025 Nagoya, Aichi-ken, Japan
- Site JP00029 Nagoya, Aichi-ken, Japan
- Site JP00040 Nagoya, Aichi-ken, Japan
- Site JP00006 Kitakyushu, Fukuoka, Japan
NCT01981941
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Chugoku, Japan
- Chūbu, Japan
- Kansai, Japan
- Kanto, Japan
Completed
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS
NCT02397057
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Coastal Clinical Research, Inc. Mobile, Alabama, United States
- Synergy San Diego National City, California, United States
- Desert Valley Research Rancho Mirage, California, United States
- Anderson Clinical Research Redlands, California, United States
NCT00256854
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- GSK Investigational Site Laguna Hills, California, United States
- GSK Investigational Site Oxnard, California, United States
- GSK Investigational Site Pasadena, California, United States
- GSK Investigational Site Reseda, California, United States
Completed
Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome
NCT01823770
- Conditions
- Cardiovascular Diseases, Dyssomnias, Mental Disorders, +6 more
- Locations
-
- UH Montpellier Montpellier, France
Completed
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
NCT01382901
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
Not specified
NCT01494766
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Seton Family of Hospitals Austin, Texas, United States
NCT00373542
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Tuscaloosa, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
NCT00314860
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Mesa, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Sun City, Arizona, United States
NCT00363857
- Conditions
- Dyssomnias, Fatigue, Mental Disorders, +9 more
- Locations
-
- GSK Investigational Site Alabaster, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Tuscaloosa, Alabama, United States
NCT00748098
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Hallandale, Florida, United States
Completed
Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
NCT01411124
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States